1. Yano Y, Reia JP, Colangelo LA, et al. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life. JAMA. 2018;320(17):177482. doi:10.1001/jama.2018.13551.
2. Sullivan JM, Vander Zwaag RV, el-Zeky F, et al. Left ventricular hypertrophy: effect on survival. J. Am. Coll. Cardiol. 1993;22:508-13.
3. Mechanick JI, Garber AJ, Grunberger G, et al. Dysglycemia-based chronic disease: An American Association of Clinical Endocrinologists Position Statement. Endocr Pract. 2018;24:995-1011. doi:10.4158/PS-2018-0139.
4. Edvardsen T, Rosen BD, Pan L, et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging — the MultiEthnic Study of Atherosclerosis (MESA) Am Heart J. 2006;151:109-14.
5. Matthews DR. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
6. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299-304. doi:10.1089/met.2008.0034.
7. Bello-Chavolla O, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes. Eur J Endocrinol 2018;178(5):533-44. doi:10.1530/EJE-17-0883. Epub 2018 Mar 13.
8. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.
9. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. JACC. 1992;19(7):1550-8.
10. Negishi K, Negishi T, Kurosawa K, et al. Practical guidance in echocardiographic assessment of global longitudinal strain. JACC Cardiovasc Imaging. 2015;8(4):489-92. doi:10.1016/j.jcmg.2014.06.013. Epub 2014 Aug 13.
11. Sundstrom J, Neovius M, Tynelius P. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ. 2011;342:d643. doi:10.1136/bmj.d643.
12. Williams B. High blood pressure in young people and premature death. BMJ. 2011;342:d1104. doi:10.1136/bmj.d1104.
13. Kishi S, Gidding SS, Reis JP, et al. Association of insulin resistance and glycemic metabolic abnormalities with LV structure and function in middle age: the CARDIA study. JACC Cardiovasc Imaging. 2017;10:105-14. doi:10.1016/j.jcmg.2016.02.033. Epub 2016 Aug 17.
14. Vishram JK, Borglykke A, Andreasen AH, et al. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) project. Hypertension. 2012 Nov;60(5):1117-23. doi:10.1161/HYPERTENSIONAHA.112.201400. Epub 2012 Sep 24.
15. Julius S, Nesbitt SD, Egan BM, et al. Hypertension Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blockers. N Engl J Med. 2006 Apr 20;354(16):1685-97. Epub 2006 Mar 14.
16. Navarini S, Bellsham-Revell H, Chubb H, et al. Myocardial deformation measured by 3-Demensional speckle tracking in children and adolescents with systemic arterial hypertension. Hypertension. 2017 Dec;70(6):1142-1147. doi:10.1161/HYPERTENSIONAHA.117.09574. Epub 2017 Oct 30.
17. Sengupta SP, Caracciolo G, Thompson C, et al. Early impairment of left ventricular function in patients with systemic hypertension: New insights with 2-dimensional speckle tracking echocardiography. Indian Heart J. 2013 Jan-Feb;65(1):48-52. doi:10.1016/j.ihj.2012.12.009. Epub 2012 Dec 26.
18. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006 May;47(5):846-53. Epub 2006 Mar 27.
19. Tientcheu D, Ayers C, Das SR, et al. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study. J Am Coll Cardiol. 2015 Nov 17;66(20):2159-2169. doi:10.1016/j.jacc.2015.09.007.
20. da Silva A, Caldas A, Hermsdorff H, et al. Triglyceride‑glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019 Jul 11;18(1):89. doi:10.1186/s12933-019-0893-2.
21. Velagaleti RS, Gona P, Chuang ML, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010 May;3(3):257-63. doi:10.1161/CIRCIMAGING.109.911438. Epub 2010 Mar 5.
22. Shah RV, Abbasi SA, Heydari B, et al. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013 Apr 23;61(16):1698-706. doi:10.1016/j.jacc.2013.01.053.
23. Ho JE, McCabe EL, Wang TJ, et al. Cardiometabolic traits and systolic mechanics in the community. Circ Heart Fail. 2017 May;10(5). pii: e003536. doi:10.1161/CIRCHEARTFAILURE.116.003536.
24. Lin JL, Sung KT, Su CH, et al. Cadriac structural remodeling, longitudinal systolic strain and torsional mechanics in lean and nonlean dysglycemic Chinese adults. Circ Cardiovasc Imaging. 2018 May;11(5):e007047. doi:10.1161/CIRCIMAGING.117.007047.
25. Cauwenberghs N, Knez J, Thijs L, et al. Relation of Insulin Resistance to Longitudinal changes in Left Ventricular Structure and Function in a General Population. J Am Heart Assoc. 2018 Mar 24;7(7). pii: e008315. doi:10.1161/JAHA.117.008315.
26. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78.
27. Rewers M, Zaccaro D, D’Agostino R, et al. Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:781-7.
28. Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012;7(12):e52036. doi:10.1371/journal.pone.0052036. Epub 2012 Dec 28.
29. Rewers M, Zaccaro D, D’Agostino HG, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-17.
30. Saad MF, Rewers M, Selby J, et al. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension. 2004;43:1324-31.
31. Velez M, Kohli S, Sabbah HN. Animal models of insulin resistance and heart failure. Heart Fail Rev. 2014 Jan;19(1):1-13. doi:10.1007/s10741-013-9387-6.
32. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008 Jan 15;51(2):93-102. doi:10.1016/j.jacc.2007.10.021
33. Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017 Mar 15;113(4):389-398. doi:10.1093/cvr/cvx012.
34. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACCF/ACC/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guidelines for the management of heart failure: a report of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi:10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.